Lupus
Can omega-3s improve lupus disease activity?
A small randomized-trial synthesis suggests a modest disease-activity benefit, with low certainty. The finding does not establish prevention of flares or organ damage.
Updated September 24, 2026 · Editorial attribution: PV Griscom, M.Sc. · Independent clinical review pending
The question behind the headline
Adults with systemic lupus erythematosus; supplementation alongside existing treatment.
What the finding does—and doesn’t—tell us
The estimated change was less than one SLEDAI point on average. Statistical evidence of a change is not necessarily a meaningful clinical improvement.
Read the underlying research.
- Effect of omega-3 fatty acids on systemic lupus erythematosus disease activity: A systematic review and meta-analysis. · 2020 ↗
- The effect of Omega-3 fatty acid supplementation in systemic lupus erythematosus patients: A systematic review. · 2022 ↗
Selected sources, not an exhaustive reference list. Rating draws on published results and review summaries; no independent full systematic review has been conducted. Source publication dates may precede this page’s update date.
Three questions to take forward
- Was the study population similar to the person or situation I have in mind?
- Did it measure an outcome people feel or experience, or only a laboratory marker?
- How do formulation, usual care, absolute benefit and adverse effects change the interpretation?
Study doses describe experiments; they are not personal dosing advice. Explore safety and limitations ↗